Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 7 4 2020
medline: 10 4 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

Left ventricular hypertrophy (LVH) is often seen in patients with primary aldosteronism (PA), and the prevalence of LVH is reportedly higher among patients with PA than patients with essential hypertension. However, the correlation between aldosterone levels and LVH is undefined, and how aldosterone affects LVH in patients with PA remains unclear. We, therefore, retrospectively assessed a large PA database established by the multicenter JPAS (Japan Primary Aldosteronism Study) to reveal the factors associated with LVH in patients with PA without suspected autonomous cortisol secretion. In the 1186 patients with PA studied, the basal plasma aldosterone concentration, plasma renin activity, and the aldosterone-to-renin ratio did not significantly correlate with left ventricular LV mass index (LVMI) in single or multiple regression analyses. However, the plasma aldosterone concentration after the captopril challenge test or saline-infusion test, which are associated with autonomous aldosterone secretion, correlated significantly with LVMI, even after adjusting for patients' backgrounds, including age and blood pressure. In addition, hypokalemia and the unilateral subtype also correlated with LVMI. Longitudinal subanalysis of medically or surgically treated patients with PA showed significant reductions in LVMI in both the surgery (63.0±18.1 to 55.3±19.5 g/m

Identifiants

pubmed: 32248705
doi: 10.1161/HYPERTENSIONAHA.119.14601
doi:

Substances chimiques

Mineralocorticoid Receptor Antagonists 0
Aldosterone 4964P6T9RB
Renin EC 3.4.23.15

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1475-1482

Commentaires et corrections

Type : CommentIn

Auteurs

Youichi Ohno (Y)

From the Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan (Y.O., M.S., N.I., A.K.).

Masakatsu Sone (M)

From the Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan (Y.O., M.S., N.I., A.K.).
Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan (M.S.).

Nobuya Inagaki (N)

From the Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan (Y.O., M.S., N.I., A.K.).

Akiyuki Kawashima (A)

From the Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan (Y.O., M.S., N.I., A.K.).

Yoshiyu Takeda (Y)

Department of Internal Medicine (Y.T.), Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Takashi Yoneda (T)

Department of Health Promotion and Medicine of the Future (T. Yoneda), Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Isao Kurihara (I)

Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan (I.K., H.I.).

Hiroshi Itoh (H)

Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan (I.K., H.I.).

Mika Tsuiki (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan (M.T.).

Takamasa Ichijo (T)

Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan (T.I.).

Takuyuki Katabami (T)

Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan (T.K.).

Norio Wada (N)

Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan (N.W.).

Ryuichi Sakamoto (R)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (R.S., Y.O.).

Yoshihiro Ogawa (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (R.S., Y.O.).

Takanobu Yoshimoto (T)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan (T. Yoshimoto, T. Yamada).

Tetsuya Yamada (T)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan (T. Yoshimoto, T. Yamada).

Junji Kawashima (J)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan (J.K.).

Yuichi Matsuda (Y)

Department of Cardiology, Sanda City Hospital, Sanda, Japan (Y.M.).

Hiroki Kobayashi (H)

Division of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine, Tokyo, Japan (H.K.).

Kohei Kamemura (K)

Division of Cardiovascular Medicine, Department of Internal Medicine, Shinko Hospital, Kobe, Japan (K.K.).

Koichi Yamamoto (K)

Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan (K.Y.).

Michio Otsuki (M)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan (M.O.).

Shintaro Okamura (S)

Departoment of Endocrinology, Tenri Hospital, Tenri, Japan (S.O.).

Shoichiro Izawa (S)

Department of Endocrinology and Metabolism, Tottori University Hospital, Yonago, Japan (S.I.).

Ryuji Okamoto (R)

Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan (R.O.).

Kouichi Tamura (K)

Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Japan (K.T.).

Akiyo Tanabe (A)

Division of Endocrinology, National Center for Global Health and Medicine, Tokyo, Japan (A.T.).

Mitsuhide Naruse (M)

Clinical Researh Institute of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center and Endocrine Center, Ijinkai Takeda General Hospital, Kyoto, Japan (M.N.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH